NASDAQ:JYNT Joint (JYNT) Stock Price, News & Analysis $7.20 -0.17 (-2.31%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$7.22 +0.01 (+0.21%) As of 10/23/2026 05:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About Joint Stock (NASDAQ:JYNT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Joint alerts:Sign Up Key Stats Today's Range$7.16▼$7.3750-Day Range$6.90▼$8.6352-Week Range$6.79▼$10.67Volume35,765 shsAverage Volume73,916 shsMarket Capitalization$101.83 millionP/E Ratio26.67Dividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview The Joint Corp. (NASDAQ: JYNT) is a healthcare services company that operates The Joint Chiropractic, a network of chiropractic clinics in the United States. The company focuses on providing routine chiropractic care intended to support musculoskeletal health, mobility and general wellness. The Joint Chiropractic clinics offer services such as chiropractic adjustments and related wellness care. The business model is designed to provide convenient, accessible care through walk-in visits, membership plans and prepaid packages, with an emphasis on transparent pricing and extended operating hours. Services are generally delivered by licensed chiropractors at individual clinic locations. Founded in 1999, The Joint Corp. has expanded primarily through a franchise-based model, supplemented by company-operated clinics. Its network serves communities across the United States under The Joint Chiropractic brand. The company is headquartered in Scottsdale, Arizona.AI Generated. May Contain Errors. Read More Joint Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreJYNT MarketRank™: 1.714876033055 of 5 starsJoint scored higher than 34% of companies evaluated by MarketBeat, and ranked 717th out of 902 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingReduce Consensus RatingJoint has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.Amount of Analyst CoverageJoint has only been the subject of 1 research reports in the past 90 days.Read more about Joint's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth116.13% Earnings GrowthEarnings for Joint are expected to grow by 116.13% in the coming year, from $0.31 to $0.67 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Joint is 26.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.78.Price to Earnings Ratio vs. SectorThe P/E ratio of Joint is 26.67, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.30.Price to Book Value per Share RatioJoint has a P/B Ratio of 7.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Joint's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.11% of the float of Joint has been sold short.Short Interest Ratio / Days to CoverJoint has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Joint has recently decreased by 7.71%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldJoint does not currently pay a dividend.Dividend GrowthJoint does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Joint this week, compared to 2 articles on an average week. Company Ownership1.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Joint insiders have not sold or bought any company stock.Percentage Held by Insiders30.20% of the stock of Joint is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions76.88% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Joint's insider trading history. Receive JYNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. JYNT Stock News HeadlinesThe Joint Corp. to Report 2026 Third Quarter Results on Thursday, November 5 and Host Conference Call and WebcastOctober 22 at 7:05 AM | globenewswire.comJoint Reacquires Regional Developer Rights Across TexasOctober 6, 2026 | marketscreener.comM“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 yearsDr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.October 24 at 1:00 AM | Weiss Ratings (Ad)The Joint Chiropractic Expands Growth Opportunities Through Strategic Territory ReacquisitionOctober 6, 2026 | prnewswire.comThe Joint Corp.(NasdaqCM:JYNT) dropped from S&P Global BMI IndexSeptember 21, 2026 | marketscreener.comMThe Joint reiterates 2026 outlook while cutting new clinic openings to 22-26August 7, 2026 | seekingalpha.comThe Joint Corp. (JYNT) Q2 2026 Earnings Call TranscriptAugust 7, 2026 | seekingalpha.comThe Joint Chiropractic Earns Entrepreneur Recognition as a Premier Multi-Unit Franchise InvestmentJuly 30, 2026 | prnewswire.comSee More Headlines JYNT Stock Analysis - Frequently Asked Questions How have JYNT shares performed this year? Joint's stock was trading at $8.72 at the beginning of the year. Since then, JYNT shares have decreased by 17.4% and is now trading at $7.20. How were Joint's earnings last quarter? The Joint Corp. (NASDAQ:JYNT) released its earnings results on Thursday, August, 6th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.00. The business earned $15.18 million during the quarter, compared to analyst estimates of $14.57 million. Joint had a net margin of 6.49% and a trailing twelve-month return on equity of 12.02%. Read the conference call transcript. Is Joint buying back stock? Joint's board authorized a stock repurchase plan on Thursday, June 5th 2025, which authorizes the company to repurchase $5,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 2.7% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's board believes its shares are undervalued. When did Joint IPO? Joint (JYNT) raised $20 million in an IPO on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.00-$7.00 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager. Who are Joint's major shareholders? Joint's top institutional investors include Skylands Capital LLC (6.69%). View institutional ownership trends. How do I buy shares of Joint? Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Joint own? Based on aggregate information from My MarketBeat watchlists, some other companies that Joint investors own include NVIDIA (NVDA), Tesla (TSLA), Salesforce (CRM), InMode (INMD), Micron Technology (MU), Advanced Micro Devices (AMD) and Intuit (INTU). Company Calendar Last Earnings8/06/2026Today10/24/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (18m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 JYNT's financial health is in the Red zone, according to TradeSmith. JYNT has been in this zone for over 18 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:JYNT CIK1612630 Webwww.thejoint.com Phone(480) 245-5960Fax480-513-7989Employees330Year Founded1999Profitability EPS (Trailing Twelve Months)$0.27 Trailing P/E Ratio26.67 Forward P/E Ratio23.23 P/E GrowthN/ANet Income$2.91 million Net Margins6.49% Pretax Margin3.61% Return on Equity12.02% Return on Assets3.47% Debt Debt-to-Equity RatioN/A Current Ratio1.83 Quick Ratio1.83 Sales & Book Value Annual Sales$58.55 million Price / Sales1.74 Cash Flow$0.10 per share Price / Cash Flow75.77 Book Value$1.01 per share Price / Book7.13Miscellaneous Outstanding Shares14,143,000Free Float9,872,000Market Cap$101.83 million OptionableOptionable Beta1.09 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:JYNT) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersHow I’m playing the AI melt-up (and down)Porter Stansberry says a powerful new market shift is forming and most investors are missing it entirely. I...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredSpaceX is worth trillions. This one's $14.It is not SpaceX, Tesla, Starlink, or Neuralink. But Elon's rocket company shows up in this stock's paperwork,...Behind the Markets | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Joint Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Joint With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
